Linfoma (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Linfoma" in Italian language version.

refsWebsite

Global rank Italian rank

16nih.gov

4^th place

9^th place

11doi.org

2^nd place

7^th place

7cancer.gov

1,684^th place

2,574^th place

6oadoi.org

799^th place

22^nd place

5web.archive.org

1^st place

3archive.org

6^th place

8^th place

2books.google.com

3^rd place

14^th place

2medscape.com

719^th place

799^th place

2who.int

195^th place

342^nd place

1google.ca

838^th place

542^nd place

1lymphoma.org

low place

1sciencedirect.com

149^th place

298^th place

1hematologylibrary.org

low place

1clinicaltrials.gov

5,225^th place

5,296^th place

archive.org

World Cancer Report 2014., World Health Organization, 2014, pp. Chapter 5.13, ISBN 92-832-0429-8.
Samuel Hellman e Mauch, P.M. Ed., Hodgkin's Disease, Chapter 1, Lippincott Williams & Wilkins, 1999, p. 5, ISBN 0-7817-1502-4.
Pathology and Genetics of Haemo (World Health Organization Classification of Tumours S.), Oxford Univ Pr, 2001, ISBN 92-832-2411-6.

books.google.com

(EN) Aditya Bardia e Eric Seifter, Johns Hopkins Patients' Guide to Lymphoma, Jones & Bartlett Learning, 22 ottobre 2010, ISBN 9781449631413. URL consultato il 18 ottobre 2017.
Alfred C. Feller e Jacques Diebold, Histopathology of Nodal and Extranodal Non-Hodgkin's Lymphomas, 3rd, Springer, 2004, ISBN 978-3-540-63801-8.

cancer.gov

seer.cancer.gov

Hodgkin Lymphoma—SEER Stat Fact Sheets, su seer.cancer.gov. URL consultato il 26 agosto 2012.
SEER Stat Fact Sheets: Non-Hodgkin Lymphoma, su NCI. URL consultato il 18 giugno 2014.
Horner MJ, Ries LAG, Krapcho M, Neyman N, et al. (eds)., SEER Cancer Statistics Review, 1975–2006, su Surveillance Epidemiology and End Results (SEER), Bethesda, MD, National Cancer Institute. URL consultato il 3 novembre 2009.
«Table 1.4: Age-Adjusted SEER Incidence and U.S. Death Rates and 5-Year Relative Survival Rates By Primary Cancer Site, Sex and Time Period»
Copia archiviata, su seer.cancer.gov. URL consultato il 26 gennaio 2007 (archiviato dall'url originale il 10 ottobre 2013). Data from the USA 1999–2006, All Races, Both Sexes: Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, Ruhl J, Howlader N, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Cronin K, Chen HS, Feuer EJ, Stinchcomb DG, Edwards BK (eds). SEER Cancer Statistics Review, 1975–2007, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2007/, based on November 2009 SEER data submission, posted to the SEER web site, 2010.

cancer.gov

General Information About Adult Hodgkin Lymphoma, su National Cancer Institute, 23 aprile 2014. URL consultato il 20 giugno 2014.
General Information About Adult Non-Hodgkin Lymphoma, su National Cancer Institute, 25 aprile 2014. URL consultato il 20 giugno 2014.
Lymphoma, su NCI. URL consultato il 13 giugno 2014.

clinicaltrials.gov

(EN) Studies found for: lymphoma, su clinicaltrials.gov.

doi.org

dx.doi.org

JW Vardiman, J Thiele, DA Arber, RD Brunning, MJ Borowitz, A Porwit, NL Harris, MM Le Beau, E Hellström-Lindberg, A Tefferi e CD Bloomfield, The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes., in Blood, vol. 114, n. 5, 30 luglio 2009, pp. 937–51, DOI:10.1182/blood-2009-03-209262, PMID 19357394.
H Tran, Nourse J, Hall S, Green M, Griffiths L e Gandhi MK., Immunodeficiency-associated lymphomas., in Blood Reviews, vol. 22, n. 5, Sep 2008, pp. 261–281, DOI:10.1016/j.blre.2008.03.009.
Elphee EE, Understanding the concept of uncertainty in patients with indolent lymphoma, in Oncol Nurs Forum, vol. 35, n. 3, maggio 2008, pp. 449–54, DOI:10.1188/08.ONF.449-454, PMID 18467294.
Bernstein SH, Burack WR, The incidence, natural history, biology, and treatment of transformed lymphomas, in Hematology Am Soc Hematol Educ Program, vol. 2009, 2009, pp. 532–41, DOI:10.1182/asheducation-2009.1.532, PMID 20008238.
Martin NE, Ng AK, Good things come in small packages: low-dose radiation as palliation for indolent non-Hodgkin lymphomas, in Leuk. Lymphoma, vol. 50, n. 11, novembre 2009, pp. 1765–72, DOI:10.3109/10428190903186510, PMID 19883306.
Kuruvilla J, Standard therapy of advanced Hodgkin lymphoma, in Hematology Am Soc Hematol Educ Program, vol. 2009, 2009, pp. 497–506, DOI:10.1182/asheducation-2009.1.497, PMID 20008235.
Ferrell B, Connor SR, Cordes A, Dahlin CM, Fine PG, Hutton N et al., The national agenda for quality palliative care: the National Consensus Project and the National Quality Forum., in J Pain Symptom Manage, vol. 33, n. 6, 2007, pp. 737–44, DOI:10.1016/j.jpainsymman.2007.02.024, PMID 17531914.
Higginson IJ, Evans CJ, What is the evidence that palliative care teams improve outcomes for cancer patients and their families?, in Cancer J, vol. 16, n. 5, 2010, pp. 423–35, DOI:10.1097/PPO.0b013e3181f684e5, PMID 20890138.
Schmidt P, Otto M, Hechler T, Metzing S, Wolfe J, Zernikow B, Did increased availability of pediatric palliative care lead to improved palliative care outcomes in children with cancer?, in J Palliat Med, vol. 16, n. 9, 2013, pp. 1034–9, DOI:10.1089/jpm.2013.0014, PMID 23901834.
Tang ST, Chang WC, Chen JS, Wang HM, Shen WC, Li CY et al., Course and predictors of depressive symptoms among family caregivers of terminally ill cancer patients until their death., in Psychooncology, vol. 22, n. 6, 2013, pp. 1312–8, DOI:10.1002/pon.3141, PMID 22836818.
Chung HM, Lyckholm LJ, Smith TJ, Palliative care in BMT., in Bone Marrow Transplant, vol. 43, n. 4, 2009, pp. 265–73, DOI:10.1038/bmt.2008.436, PMID 19151797.

google.ca

books.google.ca

Robert Marcus, Lymphoma : pathology, diagnosis and treatment, Second edition., 2013, p. 1, ISBN 978-1-107-01059-8.

hematologylibrary.org

bloodjournal.hematologylibrary.org

Radioimmunotherapy of non-Hodgkin lymphomas. Cheson BD et al. Blood. 2003 Jan 15;101(2):391-8.

lymphoma.org

About Lymphoma, su lymphoma.org, Lymphoma Research Foundation. URL consultato il 22 dicembre 2012.

medscape.com

Palliative Care: It's for Caregivers Too, Says Study, su medscape.com. URL consultato il 21 agosto 2014.
Providing Palliative Care to Family Caregivers Throughout the Bone Marrow Transplantation Trajectory, su medscape.com. URL consultato il 21 agosto 2014.

nih.gov

ncbi.nlm.nih.gov

JW Vardiman, J Thiele, DA Arber, RD Brunning, MJ Borowitz, A Porwit, NL Harris, MM Le Beau, E Hellström-Lindberg, A Tefferi e CD Bloomfield, The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes., in Blood, vol. 114, n. 5, 30 luglio 2009, pp. 937–51, DOI:10.1182/blood-2009-03-209262, PMID 19357394.
Sweetenham JW, Treatment of lymphoblastic lymphoma in adults, in Oncology (Williston Park, N.Y.), vol. 23, n. 12, novembre 2009, pp. 1015–20, PMID 20017283.
Elphee EE, Understanding the concept of uncertainty in patients with indolent lymphoma, in Oncol Nurs Forum, vol. 35, n. 3, maggio 2008, pp. 449–54, DOI:10.1188/08.ONF.449-454, PMID 18467294.
Bernstein SH, Burack WR, The incidence, natural history, biology, and treatment of transformed lymphomas, in Hematology Am Soc Hematol Educ Program, vol. 2009, 2009, pp. 532–41, DOI:10.1182/asheducation-2009.1.532, PMID 20008238.
Martin NE, Ng AK, Good things come in small packages: low-dose radiation as palliation for indolent non-Hodgkin lymphomas, in Leuk. Lymphoma, vol. 50, n. 11, novembre 2009, pp. 1765–72, DOI:10.3109/10428190903186510, PMID 19883306.
Kuruvilla J, Standard therapy of advanced Hodgkin lymphoma, in Hematology Am Soc Hematol Educ Program, vol. 2009, 2009, pp. 497–506, DOI:10.1182/asheducation-2009.1.497, PMID 20008235.
Targeted therapy of cancer with radiolabeled antibodies. Goldenberg DM. J Nucl Med. 2002 May;43(5):693-713.
The curability of tumours of differing size by targeted radiotherapy using 131I or 90Y. Wheldon TE et al. Radiother Oncol. 1991 Jun;21(2):91-9.
90Yttrium-Ibritumomab Tiuxetan Consolidation of First Remission in Advanced-Stage Follicular Non-Hodgkin Lymphoma: Updated Results After a Median Follow-Up of 7.3 Years From the International, Randomized, Phase III First-Line Indolent Trial. Morschhauser F et al. J Clin Oncol. 2013 Jun 1;31(16):1977-83.
Phase II trial of short-course R-CHOP followed by 90Y-ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients. Zinzani PL et al. Clin Cancer Res. 2010 Aug 1;16(15):3998-4004.
Ferrell B, Connor SR, Cordes A, Dahlin CM, Fine PG, Hutton N et al., The national agenda for quality palliative care: the National Consensus Project and the National Quality Forum., in J Pain Symptom Manage, vol. 33, n. 6, 2007, pp. 737–44, DOI:10.1016/j.jpainsymman.2007.02.024, PMID 17531914.
Higginson IJ, Evans CJ, What is the evidence that palliative care teams improve outcomes for cancer patients and their families?, in Cancer J, vol. 16, n. 5, 2010, pp. 423–35, DOI:10.1097/PPO.0b013e3181f684e5, PMID 20890138.
Heath JA, Clarke NE, Donath SM, McCarthy M, Anderson VA, Wolfe J, Symptoms and suffering at the end of life in children with cancer: an Australian perspective., in Med J Aust, vol. 192, n. 2, 2010, pp. 71–5, PMID 20078405.
Schmidt P, Otto M, Hechler T, Metzing S, Wolfe J, Zernikow B, Did increased availability of pediatric palliative care lead to improved palliative care outcomes in children with cancer?, in J Palliat Med, vol. 16, n. 9, 2013, pp. 1034–9, DOI:10.1089/jpm.2013.0014, PMID 23901834.
Tang ST, Chang WC, Chen JS, Wang HM, Shen WC, Li CY et al., Course and predictors of depressive symptoms among family caregivers of terminally ill cancer patients until their death., in Psychooncology, vol. 22, n. 6, 2013, pp. 1312–8, DOI:10.1002/pon.3141, PMID 22836818.
Chung HM, Lyckholm LJ, Smith TJ, Palliative care in BMT., in Bone Marrow Transplant, vol. 43, n. 4, 2009, pp. 265–73, DOI:10.1038/bmt.2008.436, PMID 19151797.

oadoi.org

JW Vardiman, J Thiele, DA Arber, RD Brunning, MJ Borowitz, A Porwit, NL Harris, MM Le Beau, E Hellström-Lindberg, A Tefferi e CD Bloomfield, The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes., in Blood, vol. 114, n. 5, 30 luglio 2009, pp. 937–51, DOI:10.1182/blood-2009-03-209262, PMID 19357394.
H Tran, Nourse J, Hall S, Green M, Griffiths L e Gandhi MK., Immunodeficiency-associated lymphomas., in Blood Reviews, vol. 22, n. 5, Sep 2008, pp. 261–281, DOI:10.1016/j.blre.2008.03.009.
Elphee EE, Understanding the concept of uncertainty in patients with indolent lymphoma, in Oncol Nurs Forum, vol. 35, n. 3, maggio 2008, pp. 449–54, DOI:10.1188/08.ONF.449-454, PMID 18467294.
Bernstein SH, Burack WR, The incidence, natural history, biology, and treatment of transformed lymphomas, in Hematology Am Soc Hematol Educ Program, vol. 2009, 2009, pp. 532–41, DOI:10.1182/asheducation-2009.1.532, PMID 20008238.
Martin NE, Ng AK, Good things come in small packages: low-dose radiation as palliation for indolent non-Hodgkin lymphomas, in Leuk. Lymphoma, vol. 50, n. 11, novembre 2009, pp. 1765–72, DOI:10.3109/10428190903186510, PMID 19883306.
Kuruvilla J, Standard therapy of advanced Hodgkin lymphoma, in Hematology Am Soc Hematol Educ Program, vol. 2009, 2009, pp. 497–506, DOI:10.1182/asheducation-2009.1.497, PMID 20008235.

sciencedirect.com

Clinical radioimmunotherapy. Knox SJ et al. Semin Radiat Oncol. 2000 Apr;10(2):73-93.

web.archive.org

The Lymphoma Guide Information for Patients and Caregivers (PDF), Leukemia and Lymphoma Society, 2013. URL consultato il 20 giugno 2014 (archiviato dall'url originale il 14 luglio 2014).
Warning Signs of Lymphoma — First Signs of Lymphoma, su lymphoma.about.com. URL consultato il 1º dicembre 2012 (archiviato dall'url originale il 18 novembre 2012).
American Society of Clinical Oncology, Five Things Physicians and Patients Should Question (PDF), in Choosing Wisely: an initiative of the ABIM Foundation, American Society of Clinical Oncology. URL consultato il 14 agosto 2012 (archiviato dall'url originale il 31 luglio 2012).
Copia archiviata, su seer.cancer.gov. URL consultato il 26 gennaio 2007 (archiviato dall'url originale il 10 ottobre 2013). Data from the USA 1999–2006, All Races, Both Sexes: Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, Ruhl J, Howlader N, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Cronin K, Chen HS, Feuer EJ, Stinchcomb DG, Edwards BK (eds). SEER Cancer Statistics Review, 1975–2007, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2007/, based on November 2009 SEER data submission, posted to the SEER web site, 2010.
(EN) The Leukemia & Lymphoma Society, Understanding Clinical Trials for Blood Cancers (PDF), su leukemia-lymphoma.org, Leukemia and Lymphoma Society. URL consultato il 19 maggio 2010 (archiviato dall'url originale il 5 gennaio 2011).

who.int

apps.who.int

Steven H. Swerdlow, International Agency for Research on Cancer e World Health Organization, WHO classification of tumours of haematopoietic and lymphoid tissues, World Health Organization classification of tumours, vol. 2, 4th, International Agency for Research on Cancer, 2008, ISBN 978-92-832-2431-0.

who.int

WHO Disease and injury country estimates, su World Health Organization, 2009. URL consultato l'11 novembre 2009.